Up a level |
Oza, Amit M. and Lorusso, Domenica and Oaknin, Ana and Safra, Tamar and Swisher, Elizabeth M. and Bondarenko, Igor M. and Huzarski, Tomasz and Klat, Jaroslav and Póka, Róbert and Viola, Luciana S. and Tankersley, Chris and Maloney, Lara and Goble, Sandra and Unger, Caro and Giordano, Heidi and Kristeleit, Rebecca S. (2017) ARIEL4: An International, Multicenter, Randomized Phase 3 Study of the PARP Inhibitor Rucaparib vs Chemotherapy in Germline or Somatic BRCA1- or BRCA2-Mutated, Relapsed, High-Grade Ovarian Carcinoma. Journal of Clinical Oncology, 35 (15). TPS5603- TPS5603. ISSN 0732-183X (Print) ; 1527-7755 (Electronic) ; 0732-183X (Linking)